Related Experiment Video

Updated: Apr 3, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

8.4K

The biological complexity of RKIP signaling in human cancers

Ammad Ahmad Farooqi1, Yiwei Li2, Fazlul H Sarkar2

  • 1Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan.

Experimental & Molecular Medicine
|September 26, 2015
PubMed

Insights

Raf kinase inhibitory protein (RKIP) is often downregulated in cancers and regulates cell death pathways. Research explores natural agents and miRNAs to boost RKIP for cancer treatment, though clinical efficacy needs further study.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Raf kinase inhibitory protein (RKIP) plays a crucial role in modulating intracellular signaling pathways relevant to cancer development.
  • RKIP is frequently downregulated in various human malignancies, suggesting its tumor-suppressive potential.
  • Understanding RKIP's regulatory mechanisms is vital for developing novel cancer therapies.

Purpose of the Study:

  • To summarize the biological complexities of RKIP regulation in cancer.
  • To focus on the roles of TRAIL signaling, microRNAs (miRNAs), and natural agents in RKIP modulation.
  • To highlight the potential of natural agents in RKIP-based cancer therapy.

Main Methods:

  • Literature review and synthesis of existing research on RKIP.
  • Analysis of studies investigating RKIP's interaction with TRAIL signaling.
  • Examination of identified protein and miRNA regulators of RKIP expression.

Main Results:

  • RKIP mechanistically influences the apoptotic regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling.
  • Natural agents show emerging potential in regulating RKIP expression in cancer cells.
  • Several proteins and miRNAs have been identified as key regulators of RKIP expression.

Conclusions:

  • RKIP's complex regulatory network offers therapeutic targets for cancer treatment.
  • Natural agents represent a promising avenue for RKIP-based cancer therapies.
  • Further research is essential to determine the preclinical and clinical efficacy of RKIP modulation and explore novel therapeutic strategies, including nanodelivery.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

914
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

7.3K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K